To include your compound in the COVID-19 Resource Center, submit it here.

BiomX’s balance

How BiomX attracted Seventure, other microbiome investors to A round

After identifying a handful of novel bacterial targets and bacteriophage candidates, BiomX Ltd. was able to attract $24 million in series A funding from some of industry's most active microbiome players.

OrbiMed Advisors, the Johnson & Johnson Innovation -

Read the full 391 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers